AZIN2
Antizyme inhibitor 2
Also known as: ADC, AZIN2_HUMAN, KIAA1945, ODC-p, ODC1L, ODCp
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q96A70
- Gene
- AZIN2
- Ensembl
- ENSG00000142920
- Chromosome
- 1
- Canonical length
- 460 aa
- Protein class
- Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Cytosol
OverviewNCBI Gene
The protein encoded by this gene belongs to the antizyme inhibitor family, which plays a role in cell growth and proliferation by maintaining polyamine homeostasis within the cell. Antizyme inhibitors are homologs of ornithine decarboxylase (ODC, the key enzyme in polyamine biosynthesis) that have lost the ability to decarboxylase ornithine; however, retain the ability to bind to antizymes. Antizymes negatively regulate intracellular polyamine levels by binding to ODC and targeting it for degradation, as well as by inhibiting polyamine uptake. Antizyme inhibitors function as positive regulators of polyamine levels by sequestering antizymes and neutralizing their effect. This gene encodes antizyme inhibitor 2, the second member of this gene family. Like antizyme inhibitor 1, antizyme inhibitor 2 interacts with all 3 antizymes and stimulates ODC activity and polyamine uptake. However, unlike antizyme inhibitor 1, which is ubiquitously expressed and localized in the nucleus and cytoplasm, antizyme inhibitor 2 is predominantly expressed in the brain and testis and localized in the endoplasmic reticulum-golgi intermediate compartment. Recent studies indicate that antizyme inhibitor 2 is also expressed in specific cell types in ovaries, adrenal glands and pancreas, and in mast cells. The exact function of this gene is not known, however, available data suggest its role in cell growth, spermiogenesis, vesicular trafficking and secretion. Accumulation of antizyme inhibitor 2 has also been observed in brains of patients with Alzheimer's disease. There has been confusion in literature and databases over the nomenclature of this gene, stemming from an earlier report that a human cDNA clone (identical to ODCp/AZIN2) had arginine decarboxylase (ADC) activity (PMID:14738999). Subsequent studies in human and mouse showed that antizyme inhibitor 2 was devoid of arginine decarboxylase activity (PMID:19956990). Alternatively spliced transcript variants have been described for this gene. [provided by RefSeq, Sep 2014]
Canonical amino-acid sequenceUniProt
460 residues, UniProt reviewed canonical sequence.
>Q96A70|AZIN2
1 MAGYLSESDF VMVEEGFSTR DLLKELTLGA SQATTDEVAA FFVADLGAIV RKHFCFLKCL
61 PRVRPFYAVK CNSSPGVLKV LAQLGLGFSC ANKAEMELVQ HIGIPASKII CANPCKQIAQ
121 IKYAAKHGIQ LLSFDNEMEL AKVVKSHPSA KMVLCIATDD SHSLSCLSLK FGVSLKSCRH
181 LLENAKKHHV EVVGVSFHIG SGCPDPQAYA QSIADARLVF EMGTELGHKM HVLDLGGGFP
241 GTEGAKVRFE EIASVINSAL DLYFPEGCGV DIFAELGRYY VTSAFTVAVS IIAKKEVLLD
301 QPGREEENGS TSKTIVYHLD EGVYGIFNSV LFDNICPTPI LQKKPSTEQP LYSSSLWGPA
361 VDGCDCVAEG LWLPQLHVGD WLVFDNMGAY TVGMGSPFWG TQACHITYAM SRVAWEALRR
421 QLMAAEQEDD VEGVCKPLSC GWEITDTLCV GPVFTPASIMLocalizationUniProt · AlphaFold · HPA
Whether an antibody against AZIN2 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.29
- Highest tissue expression
- 30 nTPM
Expression across tissuesHPA
Tissue
- testis: 30 nTPM
- spinal cord: 22 nTPM
- cerebral cortex: 12 nTPM
- midbrain: 12 nTPM
- hippocampal formation: 11 nTPM
- basal ganglia: 9.7 nTPM
Single-cell type
- late spermatids: 1,546 nCPM
- early spermatids: 330 nCPM
- microglia: 191 nCPM
- pdcs: 99 nCPM
- oligodendrocytes: 83 nCPM
- late primary spermatocytes: 80 nCPM
Immune cell
- plasmacytoid DC: 19 nTPM
- basophil: 6.5 nTPM
- memory CD4 T-cell: 1.6 nTPM
- naive CD4 T-cell: 1.6 nTPM
- naive CD8 T-cell: 1.6 nTPM
- gdT-cell: 1.4 nTPM
Brain region
- white matter: 23 nTPM
- spinal cord: 17 nTPM
- cerebellum: 14 nTPM
- basal ganglia: 13 nTPM
- medulla oblongata: 13 nTPM
- pons: 13 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.95
- gnomAD pLI
- 0
- DepMap mean gene effect
- 0.04
- DepMap dependency class
- none
OntologyGO
Biological processes
- agmatine biosynthetic process
- negative regulation of protein catabolic process
- ornithine metabolic process
- positive regulation of catalytic activity
- positive regulation of polyamine transmembrane transport
- putrescine biosynthetic process from arginine, via ornithine
- spermatogenesis
- trans-Golgi network membrane organization
Molecular functions
- ornithine decarboxylase activator activity
- arginine decarboxylase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ornithine/DAP/Arg decarboxylase
- Ornithine decarboxylase
- Alanine racemase/group IV decarboxylase, C-terminal
- Orn/DAP/Arg decarboxylase 2, N-terminal
- Orn/DAP/Arg decarboxylase 2, pyridoxal-phosphate binding site
- Orn/DAP/Arg decarboxylase 2, conserved site
- PLP-binding barrel
- Pyridoxal-dependent decarboxylase, pyridoxal binding domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of AZIN2 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads AZIN2 as an antibody target. Whether an autoantibody or antibody against AZIN2 could matter depends on whether native AZIN2 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
AZIN2 is annotated at the cell surface, where native AZIN2 is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label AZIN2 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...